Studies from Genentech Inc. Yield New Information about COVID-19 (Astegolimab or Efmarodocokin Alfa In Patients With Severe Covid-19 Pneumonia: a Randomized, Phase 2 Trial)

  • Timothy Buchman

Press/Media

Period1 Feb 2023

Media coverage

1

Media coverage

  • TitleStudies from Genentech Inc. Yield New Information about COVID-19 (Astegolimab or Efmarodocokin Alfa In Patients With Severe Covid-19 Pneumonia: a Randomized, Phase 2 Trial)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date1/02/23
    PersonsTimothy Buchman
View all 1
View less

Related content